389 related articles for article (PubMed ID: 21746763)
21. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
[TBL] [Abstract][Full Text] [Related]
22. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
[TBL] [Abstract][Full Text] [Related]
23. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
24. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
Hausser H; Kresse H
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
[TBL] [Abstract][Full Text] [Related]
25. An Overview of the Structure, Mechanism and Specificity of Human Heparanase.
Wu L; Davies GJ
Adv Exp Med Biol; 2020; 1221():139-167. PubMed ID: 32274709
[TBL] [Abstract][Full Text] [Related]
26. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies.
Gandhi NS; Coombe DR; Mancera RL
Biochemistry; 2008 Apr; 47(17):4851-62. PubMed ID: 18393439
[TBL] [Abstract][Full Text] [Related]
27. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
[TBL] [Abstract][Full Text] [Related]
28. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
29. Characterization of heparanase from a rat parathyroid cell line.
Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
[TBL] [Abstract][Full Text] [Related]
30. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
31. [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
[TBL] [Abstract][Full Text] [Related]
32. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
33. The impact of heparanese and heparin on cancer metastasis and angiogenesis.
Vlodavsky I; Abboud-Jarrous G; Elkin M; Naggi A; Casu B; Sasisekharan R; Ilan N
Pathophysiol Haemost Thromb; 2006; 35(1-2):116-27. PubMed ID: 16855356
[TBL] [Abstract][Full Text] [Related]
34. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
35. Degradation of basement membrane by prostate tumor heparanase.
Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
[TBL] [Abstract][Full Text] [Related]
36. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
37. Characterization of chondroitin sulfate lyase ABC from Bacteroides thetaiotaomicron WAL2926.
Shaya D; Hahn BS; Park NY; Sim JS; Kim YS; Cygler M
Biochemistry; 2008 Jun; 47(25):6650-61. PubMed ID: 18512954
[TBL] [Abstract][Full Text] [Related]
38. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. Biochemical analyses.
Coombe DR; Stevenson SM; Kinnear BF; Gandhi NS; Mancera RL; Osmond RI; Kett WC
Biochemistry; 2008 Apr; 47(17):4863-75. PubMed ID: 18327914
[TBL] [Abstract][Full Text] [Related]
39. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase.
Wilson JC; Laloo AE; Singh S; Ferro V
Biochem Biophys Res Commun; 2014 Jan; 443(1):185-8. PubMed ID: 24291708
[TBL] [Abstract][Full Text] [Related]
40. Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions.
Poon IK; Yee DY; Jones AL; Wood RJ; Davis DS; Freeman C; Parish CR; Hulett MD
Int J Biochem Cell Biol; 2010 Sep; 42(9):1507-16. PubMed ID: 20561914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]